(CUE) Cue Biopharma complete technical analysis [charts+indicators] | Buy/Sell Cue Biopharma | (CUE) share price targets
Complete technical analysis of Cue Biopharma (CUE) by charts plus indicators, forecast predictions and share price targets for Cue Biopharma (CUE)
Cue Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-01-09 View latest technical analysis
10 day averaged volume of Cue Biopharma is 416300
Date | Daily Closing Price | Open | High | Low | Volume |
09 Tue Jan 2024 | 3.09 | 2.81 | 3.12 | 2.81 | 2.056 times |
08 Mon Jan 2024 | 2.86 | 2.61 | 2.90 | 2.59 | 0.941 times |
05 Fri Jan 2024 | 2.62 | 2.64 | 2.73 | 2.55 | 0.637 times |
04 Thu Jan 2024 | 2.68 | 2.71 | 2.87 | 2.63 | 0.802 times |
03 Wed Jan 2024 | 2.72 | 2.86 | 2.86 | 2.70 | 0.689 times |
02 Tue Jan 2024 | 2.78 | 2.73 | 2.93 | 2.70 | 0.591 times |
29 Fri Dec 2023 | 2.64 | 2.83 | 2.83 | 2.52 | 1.838 times |
29 Fri Dec 2023 | 2.64 | 2.83 | 2.83 | 2.52 | 1.838 times |
28 Thu Dec 2023 | 2.84 | 2.85 | 2.99 | 2.76 | 0.975 times |
27 Wed Dec 2023 | 2.89 | 3.11 | 3.12 | 2.87 | 1.084 times |
Stock of Cue Biopharma (CUE) has showed a significant upmove. This could be a good time to enter in this stock!
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 3.1, for a target of 3 or 2.83
Share price targets for Cue Biopharma (CUE)
Target Type | Value |
Downside Target | 1.70 |
Downside Target | 1.93 |
Downside Target | 2.20 |
Downside Target | 2.25 |
Downside Target | 2.30 |
Downside Target | 2.52 |
Downside Target | 2.69 |
Downside Target | 2.78 |
Downside Target | 2.93 |
Downside Target | 3.08 |
Upside Target | 3.12 |
Upside Target | 3.14 |
Upside Target | 3.25 |
Intraday share price targets for Cue Biopharma (CUE)
Target Type | Value |
Downside Intraday Target | 2.75 |
Downside Intraday Target | 2.4 |
Upside Intraday Target | 3.28 |
Upside Intraday Target | 3.46 |
Downside Intraday Target | 2.93 |
Weekly technical analysis of Cue Biopharma (CUE)
Date | Weekly Closing Price | Open | High | Low | Volume |
09 Tue Jan 2024 | 3.09 | 2.61 | 3.12 | 2.59 | 1.102 times |
05 Fri Jan 2024 | 2.62 | 2.73 | 2.93 | 2.55 | 1.48 times |
29 Fri Dec 2023 | 2.64 | 2.83 | 2.83 | 2.52 | 0.408 times |
29 Fri Dec 2023 | 2.64 | 2.98 | 3.14 | 2.52 | 1.133 times |
22 Fri Dec 2023 | 2.99 | 2.82 | 3.08 | 2.69 | 0.558 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Cue Biopharma (CUE)
Date | Monthly Closing Price | Open | High | Low | Volume |
09 Tue Jan 2024 | 3.09 | 2.73 | 3.12 | 2.55 | 0.231 times |
29 Fri Dec 2023 | 2.64 | 2.54 | 3.25 | 2.25 | 1.54 times |
30 Thu Nov 2023 | 2.50 | 2.12 | 2.84 | 1.93 | 1.1 times |
31 Tue Oct 2023 | 2.10 | 2.30 | 2.30 | 1.70 | 1.298 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Cue Biopharma (CUE)
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Cue Biopharma ( (CUE) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Cue Biopharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Cue Biopharma in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Cue Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Cue Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Cue Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.79 and Cue Biopharma (CUE) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Cue Biopharma (CUE) stock. Volume based technical analysis of Cue Biopharma (CUE) stock is negative.
Cue Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Cue Biopharma ( (CUE) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Cue Biopharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Cue Biopharma in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Cue Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Cue Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Cue Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.79 and Cue Biopharma (CUE) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Cue Biopharma (CUE) stock. Volume based technical analysis of Cue Biopharma (CUE) stock is negative.
Cue Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.